Shimazu et al. (48) showed that PPARγ activation could increase the activity of Cu-Zn SOD and its free radical scavenging effect, reducing the levels of NO, COX-2, iNOS, and nitrotyrosine in cerebral ischemia models (49). The gene discussed is PPARG; the disease is Cerebral ischemia.